Questo è il testo del "Comunicato Stampa" inviato a tutta la stampa italiana nel mese di Dicembre del 1995, dal presidente dell’Associazione Universo Bambino e che è passato in totale sordina:

L’Associazione Universo Bambino di Bari, comunica:
"Lo studio presentato e pubblicato su: The Mediterranean Journal of Surgery and Medecine dal Dott. Massimo Montinari, Medico Chirurgo, Presidente dell’Associazione Universo Bambino, è riferito a 48 pazienti che si sono rivolti alla sua Associazione dopo essere stati ricoverati presso numerosi Centri Ospedalieri nazionali e stranieri; questi sono stati selezionati da ben 186 malati, affetti da patologie del SNC (Sistema Nervoso Centrale), osservati nel periodo Apr/94 - Ott/95.
Nella storia di ogni paziente si documentava l’insorgenza di segni clinici relativi al SNC ed apparato digerente, in concomitanza o immediatamente dopo la somministrazione di vaccini (per la Polio Sabin e Salk, Difterite-Tetano,  Morbillo, Difterite, Tetano, Pertosse, TBC).
La proposta di studio è riferita alla valutazione del quadro immunitario dei pazienti ed al ruolo dell’immunogenetica nella diagnosi di patologie ad eziopatogenesi spesso dubbia ed handicappanti; l’attento studio del braccio corto del Cromosoma 6 dell’uomo, la caratteristica genetica e l’azione di virus a DNA in soggetti sottoposti a vaccinoprofilassi in età pediatrica, ha consentito di valutare una caratteristica ricorrenza di alleli nel quadro genetico di tutti i pazienti sottoposti a vaccinoprofilassi e insulto da virus a DNA ".
By UNIVERSO BAMBINO -  montinari.m@libero.it

Definizione: Con il nome di cromosoma 6 si indica, per convenzione, il sesto cromosoma umano in ordine di grandezza. Come di ogni autosoma, si hanno due copie anche del cromosoma 6.
Il cromosoma 6 possiede all'incirca 170 milioni di nucleotidi. I due cromosomi 6 rappresentano all'incirca il 6% del DNA totale nelle cellule umane. Sono stati individuati oltre 1300 geni. Si ritiene però possa contenerne fino a 1600. Tra di essi, figurano oltre cento geni correlati al complesso maggiore di istocompatibilità (o MHC), meccanismo immunologico fondamentale per l'organismo umano.

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

The Mediterranean Journal of Surgery and Medecine  - (Original Articles)  -
Continua in:    Pag.1    Pag.2     Pag.3    Pag. 4   Bibliografia

REFERENCES

• Montinari M G. Favorino B,  Roberto A:  "Diagnostic Role of Immunogenetics in Post-vaccine Diseases of the Central Nervous System (CNS): Preliminary Results"

• Manfredi G., Di Napoli P.L. - Current Trends in the Immunological Therapy of Cancer

Case Reports

• Grimaldi G. - Vascular Study of the Ovary and the Fallopian Tube by a Plastic Replica Kit

• Priano E, Gatto P., Mo/fetta L., Russo A., Calcagno, S. Visco E. - Arthroscopic Treatment of the Dolorous Shoulder in Hemodialyzed Patients  

• Veneziani N., De Pasquale C., Marraudino N., Mannatrizio G., Paradiso 1K, D’Agostino D., Ferlan G., Serena D., Bernasconi A. - Gravitational  Accelerometer Used in the Swing Rate ResponsivePacer. Follow Up 36 Months

•  Messina M., Meucci D., Zingaro P., Piro E., Pavone M. -  Non-Operative Conservative  Management of Post-traumatic Pancreatic Pseudocysts in Childhood: Report on 1 Case

• More//i E., Piano A., Di Micco C., Lelli G.,Ruggiero E., Beleggia E., Imbriani E., Tota G., Ricci Barbini 1K - Management of Metastatic Germ Cell Tumours: Report of a Singlc Institution Experience

•  Regina G., Testini M., Ful/one M., Todisco C., Rossonis S.L, Zupo 1K, Resta M., Plantamura M., Greco L., Magistro G., Greco L. - Retrograde Embolization from Suhclavian and Axillary AileriessThrombosis in a Patients with Thoracic Outlet Syndrome. Case Report

• Cerretani D., Fiaschi AL, Micheli L., Runci FM, Mandro E, Giorgi G. - Buthionine Sulfoximine Modulates Glutathione Ievels Differently in
  Various Cerebral Areas ...

• Fancellu G., Pozzi Muce/li M, Moretti A., Valente M., Gui/i 5. - Surgical Treatment of Tibial Plateau Fractures

• Mondillo 5., Nami R., D’Aprile N., Paglia 5.,   Mangiacotti L., Nicoletti A., Agricola E, Bargagli G., Paiazzuoli 1K, Senesi M, Giordano N. -
  Effect of Fosinopril Therapy on Diastolic Filling Pattern in Hypertensive Patients with Left Ventricular Hypertrophy

• Fancellu G., Pozzi Mucel/i M., Valente M., Cova .A., Conte M.A. - Our Experience in Conservative Treatment of Aspecific Spondylodiscitis      

• Rigato M., Di Cosmo L., Bianchi L., Fortunato M., Fortunato D. - A Mathematical Model for the Biomedical Simulation of Gastroesophageal Reflux Prior to and Following Surgical Cardias Invagination

• Mondillo 5., Faglia 5., D’Aprile N., Giordano N, Senesi M., Kristodhullu A., Agricola E, Paiazzuoli V.  High Calcium Heparin Doses for PostInfractual Thrombosis      

• Guide for Authors

• L. Herroelen, ~J. De Keyser, G. Ehinger: Central-nervous system demyelination after immunisation with recomhinant hepatitis B vaccine. Lancet,    338: 1174-75, 1991.

• A.P. Brèzin, M. Lautier-Frau, M. Hamedani, O. Rogeaux:  Perdita di visus ed eosino/ilia dopo vaccino ricomhinante anti epatite B. The Lancet (ED.IT.) VoI 20 Aprile 1994.

• A. Svejgard, P. Platz, L.P. Ryder: Immunology Rev. 70: 193; 1983.

• 14 C’alder, 5. Owen, C. Watson et al.: Immunology today, 10:99; 1989.

• G. Laurentaci, B. Favoino: Iminunogenetica e malattie HLA Associate. Dedalo Litostampa Bari 1991.

• M. G. Montinari. La base ./ìsiopatologica della stzpsi ostinata e dell’encopresi in età pediatrica: l’impiego dei gangliosidi bovini nel loro trattamento (òsservazioni su 40 casi) XXIII Congresso della Società Italiana di Chirurgia Pediatrica, Padova, 1-3 Ottobre 1987.

• M.G. Montinari: The use of hovine gangliosides/òr treatment of chronic constzpation with encopresis in children (òhservation and treatment of   58patients 1983-1990). Mosca URSS 1991.

• L. Migliore, M. Nieri: Evaluation of twelve potential aneuploidogenic cheniicals by the in viiro human lyinphocyte micronucleus assay. Toxic in Vitro Vol 5 n0 4, pp 325-336 1991.

• I. Shrana, A. Di Sihio, A. Lomi, 14. Scarcelli: C. Mitosis and numerical chromosome aberration analyses in human lymphocytes: 10 known or suspected spindle poisons. Mutation Research, 287: 57-70. 1993.

• B.M. Miller, ID. Adler: Aneztploid induction in mouse spermatocytes mutagenesis. Mutagenesis VoI 7 n01 pp. 69- 76~ 1992. 72 MJSM - o. 2 - 1996Massimo G. Montinari et al  

• R. Gudi, Jing Xu, A. Thiiagar: Assessment of the in vivo aneupioidy/Micron ucieus assay in mouse ho ne marrow ce/is with 16 chemicais. Enviromentai and inoiecuiar mutagenesis, 20:106-116,’ 1992.

• Lise-Do re Ad/cr: Synopsis of the in vivo resuits ohtained with the 10 knowrz or suspected aneugeus tested in the GEC coiiahorative study. Mutation Research, 282 131-137 1993.
  By dr. Massimo G.Montinari M.D

Tratto da: Mediterranean.J. Surg. Med. ISSN 1122-1771 -  Vol. 4, No. 2 June 1996 - pp. 65-128

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

Altra Bibliografia
(non contemplata nello studio del dott. M. Montinari), ma che indichiamo per motivi di grande interesse e di utilità pubblica.
La dottoressa Viera Scheibner, Ph.D. è una primaria ricercatrice scientifica ormai in pensione, con dottorato in scienze naturali. Ha pubblicato 3 libri e circa 90 articoli scientifici in riviste scientifiche; è spesso convocata da avvocati per fornire rapporti medici nei casi giudiziari sui danni da vaccino.

Questa e' solo una parte della sua raccolta bilbiografica sui danni da vaccino - vedi: 1000 studi sui Danni dei Vaccini
14.   Caffey J. (1972) “On the theory  and practice of shaking infants”, Am. J. Dis. Child 124, Agosto 1972
15.   Caffey J. (1974) “The whiplash shaken infant syndrome: manual shaking by the expremities with whisplash-induced intracranial and intraocular bleeding, linked with residual permanent brain damages and mental retardation” Pediatrics 54(4):396-403
16.   Reece R. M. (1993) “Fatal child abuse and sudden infant death syndrome” Pediatrics 91:423-429
17.   Duhaime A. C., Alario A.J., Lewander W.J. et al. (1992) “Head injury in very young children mechanisms, injury types and opthalmologic findings in 100 hospitalized patiens then two years of age” Pediatrics 90(2):179-185
18.   Levine S. e Sowinski R. (1973) “Hyperacute allergic encephalomyelitis” Am. J. Phatol 73:247-260
19.   Iwasa A., Ishida S., Akama K. (1985) “Swelling of the brain caused by pertussis vaccine: its quantitative determination and the responsible factors in the vaccine” Japan J. Med. Sci. Biol. 38:53-65
20.   Munoz J. J., Aral H., Bergman R., K. E Sadowski P. (1981) “Biological activities of cristalline pertussigen from Bordetella pertussis” Infection and Immunity Settembre 1981 pp. 820-826
21.   Wilkins J. (1988) “What is ‘significant’ and DTP reactions “ (lettera) Pediatrics 81(6):912-913
22.   Devin F., Roques G., Disdier P., Rodor F. e Weiller P. J. (1996) “Occlusion of central retinal vein after hepatitis B vaccination” Lancet 347:1626, 8 Giugno 1996
23.   Goetting M. G. e Sowa B. (1990) “Retinal Haemorrhage after cardiopulmonary resuscitation in children: an etiologic evaluation” Pediatrics 85(4):585-588
24.   Jacob J. e Mannino F. (1979) “Increased intracranial pressure after diphtheria, tetanus and pertussis immunisation” AM. J. Dis. Child 133:217-218
25.   Woerner S. J.,  Abildgaard C. F. e French B. N. (1981) “Intracranial haemorrhage in children with idiophatic thrombocytopenic purpura” Pediatrics 67(4):453-460
26.   Cody C. L., Baraff L. J., Cherry J. D., Marcy S. C. e Manclark (1981) “Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children” Pediatrics 68(5):650-660
27.   Meadow R. (1995) “What is and what is not ‘Munchausen syndrome per proxy’ ? “ Arch. Dis. Child 72:534-538
28.   Yawata, Makoto (1994) “Japan’s troubles with measles-mumps-rubella vaccine” Lancet 343:105-106, 8 Gennaio 1994
29.   Higson N. (1995) “Evaluating the measles immunisation campaign” British Medical Journal 311:62
30.   Wakerfield A.J., Murch S.H., Antony A., Linnell J. e al. (1998) “Ileal-lymphoid-nodular hyperplasia, non specific colitis and persvasive developmental disorder in children” Lancet 351:637-641, 28 Febbraio 1998
31.   Ronne T. (1985) “Measles virus infection without rash in childhood is related to disease in adult life” Lancet 5 Gennaio 1985 pp. 1-5
32.   West R.O. (1996) “Epidemiologic studies of malignancies of the ovaries” Cancer, Luglio 1996 pp. 1001-07
33.   Craighead J.E. (1975) “Report of a workshop:disease accentiation after immunisation whit inctivated microbial vaccines” Infect Dis. 1312(6):749-754
34.   National Technical Information Service, Springfield, VA 22161, USA, Phone (703) 487.4650/4600
35.   Daily News di Dayton del 28 Maggio 1993 (Ohio) Parents for Vaccine safety, 251 Ridgeway Drive, Dayton OH 45459, USA, dichiarazione di K. M. Severyn R.Ph, Ph.D 
36. “Investigative Report on the Vaccine Adverse Event Reporting System”, National Vaccine Information Center (NVCIC), 512 Maple Avenue West 206, Vienna, VA 22180, USA tel. (703) 938.0432
37.   Scheibner Viera, Ph. D. “Vaccination: 100 Years of Orthodox researce Shows that Vaccines Represent a medical Assault on the Immune System”.
38.   Torch, W.C. “Diphtheria-Pertussis-Tetanus (DPT) immunisations: A potential cause of the sudden infant death syndrom (SIDS)”, American Academy of neurology, 34th Annual Meeting, riportato in Neurology 32 (4), Pt 2
39.   Commenti sul “disorientamento” negli studi sulle reazioni ai vaccini: Fine, P.E. e Chen R.T., Division of Immunisation, Center for Disease Control and prevention, Atalanta, GA 30333, USA 15 Gennaio 1994
40.   “Nature and Rates of Adverse Reactions Associated with DPT and DT Immunisations in Infants and childrens DPT Report” The Fresno Bee, Community Relations 1626 Street, Fresno, CA 93786, USA 5 Dicembre 1984
41.   Trollfors B. and Rabo E. “Whooping cough in adults” British medical Kournal 696-97, 12 Dic. 1981
42.   National Vaccine Injury Compensation Program (NVICP) Helath Resource and Services Administration, Parklawn Building, Toom, 7-90, 5600 Fisher Lane, Rocjville, MD 20875, USA, Phone 1800.338.2382 USA
43.   “Measles vaccine failures: Lack of sustained measles-specific immunoglobulin-G responses in revaccined adolescents and young adults” Department of Pediatrics, Georgetown University Medical Center, Washington, DC 20007 in Pediatrics Infection Disease Journal 13 (1) 34-8 Gennaio 1994
44.   “Measles outbreak in 31 schools: risk factors for vaccine failure and evaluationa of a selective revaccination strategy”, Department of Preventive Medecine and Biostatistics" University of Toronto, Ontario, Canada, in Canadian medical Association Journal, 150 (7) 10933-8 1 Aprile 1994
45.   “Haemophilus B disease after vaccination with haemophilus B polysaccharide or coniugate vaccine”, Institution Division of Bacterial Products. Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892 USA, in American Journal of Disease of Children 145 (12) 1379-82 Dicembre 1991
46.   “Sustained Transmission of Mumps in a highly Vaccinated population: Assessement of Primary Vaccine Failure and Vaccine-induced Immunity”, Division Field of Epidemiology Centers for Disease Control Prevention, Atalanta, Georgia, USA, in Journal of Infection Diseases 169 (1) 77-82 – 1 Gennaio 1994
47.   “Secondary Measles Vaccine Failure in health Workers exposed to Infected Patients”, Department Of pediatrics, Children’s Hospital of Philadelphia, PA 19104, USA, in Infection Control & Hospital Epidemiology 14 (2) 81-6, Febbraio 1993
48.   Morbility and Mortality Weekly Report (MMWR) 38 (8-9), 29 Dicembre 1989
49.   “Measles”, MMWR 38:329-330, 1989
50.   MMWR 34 (24), 22 Giugno 1984
51.   “Failure to reach the goal of Measle infection in Immunized persons: Apparent paradox of measle infection in Immunized persons”. Department of Internal Medecine, Mayo Vaccine Research Group, Mayo Clinic and Foundation, Rochester, MN, USA, in Archives of Internal Medecine 154 (16) 1815-20, 22 Agosto 1994
Contiene circa 50 riferimenti bibliografici.
52.   Clinical Immunology and Immunopathology 79 (2) 163-170, Maggio 1996
53.   Gunn, Trevor, Mass Immunisation, A Point in Question, p.15
54.   Hume, E. D. Pasteur Exposed: The False Foundation of Modern Medecine, Brookreal, Australia, 1989
55.   Physician William Howard Hay’s adress of 25 June 1937
56.   Stampati in US Congressional Record
57.   “Outbreak of Paralityc Poliomyelitis in Oman: Evidence for Widespread transmission among fully Vaccineted Children”, The Lancet 338:715-720, 21 Settembre 1991
58.   Miller, Neil Z., “Vaccines: Are They Really Safe and Effective ?”, New Atlantean Press, MN, USA 1993, p.33
59.   Chicago Department of Health, Chicago, Illinois
60.   Miller, op.cit, pp. 18-40
61.   Op. cit., pp. 45-46 – anche NVIC News, Aprile 1992, p.12
62.   Curtis S.: A Handbook of Homeopathic Alternatives to Immunisation
63.   Huff, Darrell, How to Lie With Statistics, Pnguin, UK, 1973, p. 84 (1° pubblicazione di V. Gollancz 1954)
64.   Keith Bolck, M. D. Ph D. di Evanston, Illinois, ha trascorso anni raccogliendo dati sulla letteratura medica dell’immunizzazione.
65.   Lancet 1995 - 345:1071-1074 riferisce lo studio di ricercatori americani che confermano le nostre affermazioni: “Il virus del morbillo iniettato con le vaccinazioni, persiste nell’intestino dei vaccinati segnalando un’alterazione dell’assetto immunitario dei soggetti sottoposti alla profilassi vaccinale, generando le più disparate malattie dell’apparato gastrointestinale”.
66.   Libro del dott. Leonard Horowitz, “Emerging Viruses: Aids and Ebola, Nature, Accidental or Intentional ?”

Altra BIBLIOGRAFIA sui Danni da Vaccino
1.       National Technical Information Service, Springfield, VA 22161, USA, tel. (703) 487.4650.
2.       Daily News di Dayton, 28 MAG. 1993 (OHIO “Parents for Vaccine Safety”, 251 Ridgeway Drive, Dayton, OH  45459, USA), K.M. Serveryn, R.Ph, PhD.
3. “Investigative Report on the Vaccine Adverse Event Reporting System”, National Vaccine Information Center (NVIC), 512 Maple Avenue West, 206, Vienna, VA 22180, USA, tel. (703) 938.0342.
4. Scheibner, Viera, Ph. D., Vaccination: “100 Years of Orthodox Research Shows that Vaccínes Represent a Medical Assault on the Immune System,” Scheibner Publication, Blackheath, NSW, Australia, 1993.
5. Torch, W.C., “Diphtheria-Pertussis-Tetanus (DPT) immunisation: A potential cause of the sudden infant death syndrom (SIDS)”, American Academy of Neurology, 34th Annual Meeting (25 APR. - 1 MAG. 1982), riportato in Neurology 32(4), Pt 2.6. Commenti sul “disorientamento” negli studi sulle reazioni ai vaccini: Fine, P.E. e Chen, R.T., Division of Immunisation, Center for Disease Control and Prevention, Atlanta, GA 30333, USA, in American Journal of Epidemio­logy 139(2):229-30, 15 GEN. 1994 (articolo su rivista, con altri 38 riferimenti bibliografici).
7. “Nature and Rates of Adverse Reactions Assicoated with DPT e DT Immunisations in Infants and children”, Pediatrics, Vol. 68, no. 5, NOV. 1981.
8. “DPT Repor”, The Fresno Bee, Community Relations, 1626 e. Street, Fresno, CA 93786, USA, 5 DIC. 1984.
9. Trollfors, B. e Rabo, E., “Whooping cough in adults", British medical Journal 696-97, 12 SET. 1981.
10. National Vaccine Injury Compensation Program (NVICP), Health Resources and Services Administration, Parklawn Building, Room 7-90, 5600 Fisher Lane, Rockvílle, MD 20875.
11. “Measles vaccine failures: lack of sustained measles-specific immunoglobulin-G responses in revaccinated adolescents and young adults”, Departmen of Pediatrics, Georgetown University Medical Center, Washington, DC 20007, in Pediatric Infectìon Disease Journal 13(1):34-8, GEN. 1994.
12. “Measles outbreak in 31 schools: risk factors for vaccine failure and evaluation of a selective revaccination strategy”, Depatment of Preventive Medicine and Biostatistics, University of Toronto, Ontario, Canada, in Canadian Medical Association Journal 150(7):1093-8, 1 APR. 1994.
13. “Haemophilus b disease after vaccination with Haemophilus b polysaccharide or conjugate vaccine”, Institution Division of Bacterial Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA, in American Journal of Disease of Children 145(12):1379-82, DIC. 1991.
14. “Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity”, Division Field of Epidemiology, Centers for Disease Control Prevention, Atlanta, Georgia, USA, in Journal of Infection Diseases 169(1):77-82, 1 GEN. 1994.
15. “Secondary measles vaccine failure in healthcare workers exposed to infected patients”, Department of Pediatrics, Children's hospital of Philadelphia, PA 19104, USA, in Infection Control & Hospital Epidemiology 14(2):81-6, FEB. 1993.
16. Morbidity and Mortality Weekly Report MMWR 38(8-9), 29 DIC. 1989.
17. “Measles" MMWR 38:329-330, 1989.
18. MMWR 34(24). 22 GIU. 1984.
19. “Failure to reach the goal of measles elimination: Apparent paradox of measles infection in immunized persons”. Department of Internal Medicine, Mayo Vaccine Research Group, Mayo Clinic and Foundation, Rochester, MN, USA, in Archives of Internal Medicine 154(16):1815-20, 22 AGO. 1994 (rivista, con altri 50 riferimenti bibliografici).
19.a. Clinical Immunology and Immunopathology 79(2):163170. MAG. 1996.
20. Gunn, Trevor, “Mass Immunisation, A Point in Questìon”, p. 15. (Vedi anche Hume, E D., Pasteur Exposed. The False Foundation of Modern Medicine, Bookreal, Australia, 1989.)
21. Physician W. Howard Hay’s address of 25 June 1937. Stampato in US Congressional Record.
22. “Outbreak of paralytic poliomyelitis in Oman: evidence for widespread trasmission among fully vaccinated children”,  The Lancet 338:715-720, 21 SET. 1991.
23. Miller, Neii Z., Vaccines: Are 77 “Really Safe and Effective?”, ­New Atlantean Press, NM USA, 1993, p. 33­.
24. Miller, op. cit., pp. 18-40.
25. op. cit., pp. 45-46. - Vedere anche NVIC News, APR. 1992, p. 12.
26. Curtis, S.,  A Handbook of Homeopathic Alternatives to Immunisation.
27. Huff, Darrell, “How to Lie with Statistics”, Pinguin, UK, 1973, p. 84 - prima pubblicazione di Victor Gollancz, 1954.
28. Internet, attribuito a Keith Block, M. D., medico di famiglia di Evanston, Illinois, USA, che ha raccolto per anni i dati sulla letteratura medica dell'immunizzazione vaccinale.
29. Gunn, op. cit., p. 15. + op. cit, p. 21.
30. British Medical Council Publication 272. MAG. 1950.
31. Gunn, ibid.; Miller, op. cit, p. 47; Buttram, M.D. e Hoffman, Mothering Magazine, Inverno 1985, p. 30; Kalokerinos, M.D., e Dettman, M.D., “The dangers of Immunisation”, Biological Research Institute, Australia, 1979, p. 49.
32. J. Kalokerinos, Archie, M.R. “Every Second Child”, Keats Publishing Inc., New Canaan, CT, USA, 1981 (prima pubblicazione 1974 di Nelson, Australia).
33. Riportato da K. M. Severyn, R.Ph., Ph.D., nel Daily News di Dayton, 3 GIU. 1995.
34. Vaccine Information and Awareness, “Measles and Antibody Titre Levels”, Vaccine Weekly, GEN. 1996.
35. “Consumer Group Warns, Use of New Chicken Pox Vaccine in All Healthy Children May Cause More Serious Disease”, NVIC, Vienna VA, USA (comunicato stampa), citazione da The Lancet
36. Hearing before the Commettee on Interstate and Foreign Commerce, House of Representatives, 87th Congress, Second Session on H.R. 10541, MAG. 1962, p. 94.
37. Ulman, Discovering Homeopathy, p. 42; Bradford, Thomas L. ­ Logic Figures, pp. 68, 113-146; Coulter, Dividead Legacy, vol. 3 p.268
38. Golden, Isaac, “Vaccination ? A Review of Risks and Alternatives”.
39. Allan Phillips è un ricercatore indipendente e ricercatore sui danni dei vaccini. Ha scritto numerosi articoli giornalistici numerose riviste e giornali a livello mondiale; Una sua ricerca molto dettagliata è stata pubblicata nell'edizione dell'aprile 1996 della rivista Wildfire; suoi articoli dettagliati sono stati pubblicati anche sulla rivista internazionale Nexus negli anni 1998 e 1999. Riconoscimenti accademici: laurea con lode, l'elezione nella Phi Kappa Phi National Honor Society e nella National Dean's List.
40. Zitchenko. A.P.: Zh Nevropal Psikhial. 1965.- 63:1634
41. Herrlich,: A Handbuch der Schutzimpfungen. Springer Verlag 1965
42. Buchwald. G.: “Ist dit Multiple Sklerose­ eine Folge der  Pochensghutz-Wiederimpfung ? “ Der deutesche Arzt 1972:3
43. Stickl, H: “Die Beurteilung von impfschaden. Rechtsfragen und Begutachtung”. Die Medizinisch Welt. 1972:1945 - 7
44.   Stickl: Weber Schutzimpfungen p 101
45. Grimm. J.:Sinnecker, H.: “Vortrag auf dem Toltwut-Symposium des Istituis fur Poliomyelitis und Virusenzephalitiden der AMW Moskau und des Epidermio-logischen Zentrums der Staadichen Iilygieneinspektion”, Postdam 1977
46. Kuvert.;  E; Werner. J. “ ZBI Bakteriol. Parasitenkd Infect” – Kr. U. Hyg. 1 Abt. Orig. A 239, 1977:437b
47. Rogerson, R. J. Nye, F. J.: ”Hepatitis B Vaccine associated with crythema nodosum and polyarthritis”, BMJ,  1990. 301:345
48. Classen. J.B. “Cildhood immunisation and diabetes mellitus”, New Zeal Medecine Journal MAG. 1996. 24:195
49. Centnim voor Geneesimiddelenbcwaking.“Overgevoeligheid bij vaccinate legen hepatitis B, Folia Pharm, 1992. 1974:31-2
50. Biasi. D.; et al “A new case of reactive arthritis after hepatitis B vaccination”, Clin exp rheumatology, 1993:11:215
51. Anchulla. E.;  et al “Reactive arthritis after hepatitis B vaccination”. Journal Rheumatology 1990; 17,1250-1
52.   Wells,  C.E.C.; “A  neurological note on vaccination again, Influenza”. BMJ. 1971: 3:755-6
53. Bienfang, D.C. et al “Ocular abnormalities after influenza immunization”. Arch Ophtamology 1977: 96:1649
54. Perry, H.D.: Mallen. F.J.: Grodin, R.W.; Cossari,  A.J.: “Reversible blindness in optic neuritis associated with influenza vaccination”. Arch Ophtamology, 1979: 11:545-50
55. Behan, P. O. ; “Diffuse myelitis associated with rubella vaccination”. BMJ. 1977: 11-166
56. Kline. L.B.: Margulies. S.I.; Oh. S.J.; “Optic neuritis and myelitis following rubella vaccination”. Arch neurology 1982: 19-443.6
57. Pollard, Seby G.; “Relapxing neuropathy due to toxoid” Journal Neurology Science 1978: 371-2:13-125
58. Kazarian. EL: Gager. W.E.: “Optic neuriting complicating measles, mumps, and rubella vaccination”. American Journal Ophtalmology 1978: 87674:544-547
59. Shaw. F.E. : e.a. “Postmarketing surveillance for neurologic adverse events reported hepatitis B vaccination”. American  Journal Epidemiology 1988; 127/2:337-52
60. Topaloglo. H.: “Optic neuritis and myelitis after booster tetanus toxoid vaccination” Lancet 1992: I:178-9
61. Hoh. S.: Hudgings. D.: Krishanan K. R. Critchley. E.M.R. “Diffuse myelitis associated with rubella vaccination” BMJ 1976: 6043 II:1037-8
62. Behan. P.O. : “Diffuse myelitis associated with rubella vaccination”. BMJ. 1977:II:166
63. Henichel. G.M. “Neurological complications of immunization”. Ann Neurology 1982:12:119-28
64. Shaw F.E. c.a. “Postmarketing surveillance for neurologic adverse events reported after hepatitis B vaccination”. American Journal Epidemiology 1988: 127/2:337-52
65. VAERS, Nov 1990-LUG. 1992
66. Joyee, A.: Rees, J.E. : “Transverse myelitis after measlecs, mumps and rubella vaccine”. BMJ. 1995:311:422
67. Appelbaum, E.: Gireenberg M: Nelson J. “Neurological complications following antirabies vaccination”. JAMA, 1953: 151: 188-91
68.   Harrington, R.B. Olin. R.: “Incomplete transverse following rabies duck embryo vaccination” JAMA, 1971: 217:2137.8
69.   Miller, H.G.: Station J.B.: “Neurological sequelas of prophylactic inoculation”. Q. Journal. Medecine. 1954: 23:1-27
70.   Broadbank, "1" W.: “Postvaccinal myelitis” JAMA, 1931: 97:227-8
71.   Painc. R.S. Byers, R.K.: “Transverse myelopathy in children”. American Journal Disease Children 1953: 85:151-63
72.   Whittle, E. Roberton. N.R.C.: “Transverse myelitis after diphtheria, tetanus and polio immunisation”. R.M.J. 1977: 1450-51
73.   “Autoimmunhepatitis durch Hepatitis A” - Impfstoff (HAVRIX u.a.) a-L 1996: 10:103
74.   Odent, M.: Culpin. E.: Kimmel, T.: “Pertussis Vaccination and Asthma: Is there a link ? ” JAMA   1994:272/592-3
75.   Lohiya, G.: “Asthma and urticaria after hepatitis B vaccination”. West Journal Medecine 1987:147-341

Continua in     Pag.1    Pag.2     Pag.3    Pag. 4   Bibliografia

vedi anche: Ruolo dei Vaccini nella Guerra del Golfo  +  Contenuto dei Vaccini  +  Uranio e Vaccini - 1  +  Uranio e Vaccini - 2  +  Guerra del Golfo, Uranio o Vaccini ?  +  Come si producono i Vaccini  +  Uranio 1  +  Uranio 2

Pag.1       Pag.2      Pag.3     Pag. 4    
Interrogazione Parlamentare
 

HOME

BACK